OpenNashEarnings

Humana (HUM) · Health Insurance

Humana Q2 2026 earnings: summary, key numbers & outlook

Results filed 29 Jul 2026 · Quarter ended 30 Jun 2026

Press release ↗Investor relations ↗

Summaries and transcripts are machine-generated and can contain errors.

In brief

Humana's individual Medicare Advantage membership is on track to grow about 25% this year, while CenterWell primary care added 27% more patients and Humana won a statewide Illinois Medicaid contract.

Humana's customer-led benefit strategy and revised customer service approach are driving individual Medicare Advantage growth, with year-to-date membership up about 1,204,000, or 23%. Stand-alone Part D grew about 50%, mostly in Basic and Value plans. CenterWell primary care reached about 622,000 patients and 398 centers, helped by The Villages Health and MaxHealth acquisitions. Humana also won Illinois Medicaid and had its Florida contract extended to 2035.

Management is steering toward a return to a pre-tax margin of at least 3% in 2028. It plans to get there through 2027 individual MA bids, a push back to top-quartile Star Ratings, and cost discipline. The main tension is that a large base of new members runs at a higher benefit ratio, and the 2026 Star Ratings shortfall still weighs on the year. Management has also said it expects to give an investor update on December 10, 2026.

No call transcript for this quarter, so this summary also draws on: The Motley Fool (via Webull) ↗.

Key numbers

Total revenues · GAAP
$40.9B

vs $32,388 in 2Q25

Diluted EPS · GAAP
$5.73

vs $4.51 in 2Q25

Adjusted diluted EPS · non-GAAP
$7.61

vs $6.27 in 2Q25

Insurance segment benefit ratio · GAAP
91.2%

vs 89.9% in 2Q25

Segment or metricValueChange
Insurance segment revenues$39.1Bvs $31,094 in 2Q25
CenterWell segment revenues$6.8Bvs $5,537 in 2Q25
Individual MA membership growth (YTD)approximately 1,204,000up 23% year to date
Individual stand-alone PDP growth (YTD)approximately 1,139,000up 50% year to date
Group MA membership growth (YTD)approximately 159,000up 28% year to date
Medicaid membership growth (YTD)approximately 93,000
CenterWell primary care patientsapproximately 622,000up 130,900, or 27%, since December 31, 2025
CenterWell primary care centers398up 63 centers, or 19%, year over year
Where each number comes from
  • Total revenues: “Humana Inc. Summary of Results($ in millions, except per share amounts) | 2Q26 (a) | 2Q25 (a) | YTD 2026 (a) | YTD 2025 (a) Revenues | $40,867 | $32,388 | $80,515 | $64,500”
  • Diluted EPS: “Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis”
  • Adjusted diluted EPS: “Reports 2Q26 earnings per share (EPS) of $5.73 on a GAAP basis, Adjusted EPS of $7.61; reports year to date (YTD) 2026 EPS of $15.55 on a GAAP basis”
  • Insurance segment benefit ratio: “2Q26 Insurance segment GAAP benefit ratio of 91.2 percent, in line with management's guidance of 'slightly above 91 percent'; affirms full year (FY) 2026 Insurance segment benefit ratio guidance”
  • Insurance segment revenues: “Insurance Segment Results($ in millions) | 2Q26 (a) | 2Q25 (a) | YTD 2026 (a) | YTD 2025 (a) Revenues | $39,140 | $31,094 | $77,199 | $62,031”
  • CenterWell segment revenues: “CenterWell Segment Results($ in millions) | 2Q26 | 2Q25 | YTD 2026 | YTD 2025 Revenues | $6,790 | $5,537 | $12,890 | $10,632”
  • Individual MA membership growth (YTD): “2Q26 YTD membership increase of approximately 1,204,000, or 23%, is tracking in line with our FY 2026 expectation of approximately 25% membership growth”
  • Individual stand-alone PDP growth (YTD): “2Q26 YTD membership growth of approximately 1,139,000, or 50%, which is largely concentrated in our Basic and Value PDP plans”
  • Group MA membership growth (YTD): “2Q26 YTD membership growth of approximately 159,000, or 28%, is in line with expectations of growth of approximately 150,000 members in FY 2026”
  • Medicaid membership growth (YTD): “2Q26 YTD Medicaid member growth of approximately 93,000, largely driven by the start of programs in Michigan, Illinois and South Carolina”
  • CenterWell primary care patients: “Serving approximately 622,000 patients as of June 30, 2026, an increase of 130,900 patients, or 27%, from December 31, 2025.”
  • CenterWell primary care centers: “Operating 398 centers as of June 30, 2026, representing growth of 63 centers, or 19%, year over year”

Copied from the press release ↗ and other documents in the SEC filing ↗. A figure is published only if its sentence is in those documents.

From the filingQ2 2026vs year agovs last quarter
Revenue$40.9B+26.2%+3.1%
Operating income$1.4B+23.9%−22.5%
Net income$694.0M+27.3%−41.5%
Diluted EPS$5.73+27.1%−41.7%
Free cash flow$1.8B+58.5%+61.9%
Operating margin3.3%−0.1 pts−1.1 pts

Calculated by code from XBRL, not by the model.

Outlook

MetricPeriodOutlook
Adjusted EPSFY 2026 Adjusted EPSat least $9.00
GAAP EPSFY 2026 GAAP EPSat least $6.52
Consolidated revenuesFY 2026At least $160 billion
Insurance segment benefit ratioFY 202692.75% +/- 25 bps
Consolidated operating cost ratioFY 202610.0% +/- 25 bps
Effective tax rateFY 2026approximately 25.5%
Cash flows from operationsFY 2026$2.5 billion to $2.9 billion
Capital expendituresFY 2026approximately $650 million
Adjusted EPSthird quarter of 2026approximately ($1.00)
Insurance segment benefit ratiothird quarter of 2026slightly above 94%

Key takeaways

  1. Individual Medicare Advantage growth is on plan

    Year-to-date individual MA membership rose about 1,204,000, or 23%, against a full-year expectation of about 25%. Management credits new sales and better retention from its customer-led benefit strategy and changes to customer service.

  2. CenterWell primary care is scaling through acquisitions

    Primary care served about 622,000 patients, up 27% since year-end, across 398 centers. Growth came from de novo centers, mature centers and IPAs, with The Villages Health and MaxHealth adding centers.

  3. Humana expanded its Medicaid footprint

    Humana won a statewide Illinois HealthChoice Medicaid contract, going live in January 2027, as the only new entrant alongside five incumbents. Its Florida contract was extended through January 31, 2035, though procurement challenges continue on Texas and Georgia awards.

  4. Stand-alone Part D membership has surged

    Individual PDP membership grew about 1,139,000, or 50%, year to date, concentrated in Basic and Value plans. That is in line with Humana's expectation of about 1 million members for the year.

  5. Star Ratings recovery is central to the 2028 plan

    Management is focused on top-quartile Stars results in Bonus Year 2028 and reports that the rate of improvement outpaced the four-year historical growth rate in 11 of 12 selected HEDIS and Patient Safety measures. Humana's appeal of the 2025 Star Ratings ruling remains pending.

Charts

Revenue$40.9B+26.2% y/yQ2 2026
Q4 2024: $29.2B (worked out from the annual figure)Q4 ’24$29.2BQ1 2025: $32.1BQ1 ’25$32.1BQ2 2025: $32.4BQ2 ’25$32.4BQ3 2025: $32.6BQ3 ’25$32.6BQ4 2025: $32.5B (worked out from the annual figure)Q4 ’25$32.5BQ1 2026: $39.6BQ1 ’26$39.6BQ2 2026: $40.9BQ2 ’26$40.9BQ3 2026: $41.2BQ3 ’26$41.2B

Fourth quarter worked out from the annual figure.

Data
Q4 2024$29.2B *
Q1 2025$32.1B
Q2 2025$32.4B
Q3 2025$32.6B
Q4 2025$32.5B *
Q1 2026$39.6B
Q2 2026$40.9B
Q3 2026$41.2B
Diluted EPS (GAAP)$5.73+27.1% y/yQ2 2026
Q1 2025: $10.30Q1 ’25$10.30Q2 2025: $4.51Q2 ’25$4.51Q3 2025: $1.62Q3 ’25$1.62Q1 2026: $9.83Q1 ’26$9.83Q2 2026: $5.73Q2 ’26$5.73Q3 2026: $1.33Q3 ’26$1.33
Data
Q1 2025$10.30
Q2 2025$4.51
Q3 2025$1.62
Q1 2026$9.83
Q2 2026$5.73
Q3 2026$1.33

Fourth-quarter EPS appears once the press release is read; filings report it only for the full year.

Operating margin3.3%−0.1 pts y/yQ2 2026
Q4 2024: -1.9%Q4 ’24-1.9%Q1 2025: 6.3%Q1 ’256.3%Q2 2025: 3.4%Q2 ’253.4%Q3 2025: 1.2%Q3 ’251.2%Q4 2025: -2.5%Q4 ’25-2.5%Q1 2026: 4.4%Q1 ’264.4%Q2 2026: 3.3%Q2 ’263.3%Q3 2026: 0.2%Q3 ’260.2%
Data
Q4 2024-1.9%
Q1 20256.3%
Q2 20253.4%
Q3 20251.2%
Q4 2025-2.5%
Q1 20264.4%
Q2 20263.3%
Q3 20260.2%
Free cash flow$1.8B+58.5% y/yQ2 2026
Q4 2024: -$682.0MQ4 ’24-$682.0MQ1 2025: $236.0MQ1 ’25$236.0MQ2 2025: $1.2BQ2 ’25$1.2BQ3 2025: $836.0MQ3 ’25$836.0MQ4 2025: -$1.9BQ4 ’25-$1.9BQ1 2026: $1.1BQ1 ’26$1.1BQ2 2026: $1.8BQ2 ’26$1.8BQ3 2026: $2.0BQ3 ’26$2.0B
Data
Q4 2024-$682.0M
Q1 2025$236.0M
Q2 2025$1.2B
Q3 2025$836.0M
Q4 2025-$1.9B
Q1 2026$1.1B
Q2 2026$1.8B
Q3 2026$2.0B

Operating cash flow minus capital expenditure, from cash flow statements.

Questions

How fast is Humana's Medicare Advantage business growing?

Individual MA membership is up about 1,204,000, or 23%, year to date, tracking Humana's full-year expectation of about 25% growth. Group MA is up about 159,000 and stand-alone PDP about 1,139,000.

What is happening at CenterWell?

CenterWell primary care reached about 622,000 patients and 398 centers, growing 27% in patients since year-end, partly through The Villages Health and MaxHealth acquisitions. Pharmacy volumes are rising with Humana membership and a growing client base outside Humana.

What Medicaid progress did Humana report?

Humana won a statewide Illinois HealthChoice contract starting January 2027 and had its Florida contract extended through January 31, 2035. It is still working through procurement challenges on awards in Texas and Georgia.

What is Humana's long-term strategy?

Management is targeting a sustainable pre-tax margin of at least 3% in 2028, relying on 2027 individual MA bids, a return to top-quartile Star Ratings, and discipline in pricing, clinical care and costs. It plans a virtual investor update on December 10, 2026.

Are medical costs behaving as Humana expected?

Management says medical and pharmacy cost trends are in line with its 'high single digit' expectation for both new and existing members. It has seen slight favorability in inpatient care, mostly among members with value-based providers.

Documents

SEC filing